Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases
s.l; s.n; 2006. 4 p. ilus.
Non-conventional
em En
| SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP
| ID: biblio-1241809
Biblioteca responsável:
BR191.1
Localização: [{"text": "BR191.1", "_a": "09363/S"}]
ABSTRACT
Humanized monoclonal antibodies to tumor necrosis factor- alpha are valuable for the treatment of rheumatologic conditions, but they have been associated with the development of serious infections. We report the first 2 cases of leprosy developing after treatment with infliximab. After discontinuation of infliximab, both patients developed type 1 ([quot ]reversal[quot ]) leprosy reactions.
Buscar no Google
Coleções:
06-national
/
BR
Base de dados:
HANSEN
/
HANSENIASE
/
SES-SP
/
SESSP-ILSLACERVO
Assunto principal:
Artrite
/
Hanseníase Dimorfa
/
Fator de Necrose Tumoral alfa
/
Antirreumáticos
/
Glucocorticoides
/
Hansenostáticos
/
Anticorpos Monoclonais
Limite:
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2006
Tipo de documento:
Non-conventional